Optometrists in Lowell, MI Accepting Medicare
6 Optometrists found. Showing 1 - 6
 James A Kaltz, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2186 W Main St Ste 2, Lowell, MI 49331 Phone: 616-897-2020 |
 Dr. Heidi Marie Gordon, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2186 W Main St, Lowell, MI 49331 Phone: 616-897-2020 Fax: 616-897-2041 |
 Lowell Vision Center, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2186 W Main St, Lowell, MI 49331 Phone: 616-897-2020 Fax: 616-897-2041 |
Dr. Sarah Marie Weeks, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2186 W Main St, Ste. 2, Lowell, MI 49331 Phone: 616-897-2020 Fax: 616-897-2041 |
Advanced Eyecare Professionals Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1335 W Main St, Suite A, Lowell, MI 49331 Phone: 616-897-7000 Fax: 616-897-5604 |
Dr. Gerald Lawrence Almy Ii, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 505 W Main St, Lowell, MI 49331 Phone: 616-897-0330 Fax: 616-897-8744 |
News Archive
Tips for seniors to avoid serious complications from prescription meds
For seniors, October is a month in which medications - particularly prescription meds - will likely be on their minds. Not only is October national "Talk About Prescriptions Month," but Oct. 15 marks the start of Medicare's Annual Election Period during which beneficiaries can disenroll from, switch or enroll into a Medicare Advantage or Part D plan.
GFF launches education campaign to stop violence against women in DRC, prevent HIV/AIDS in military
The Gertler Family Foundation, in partnership with the Armed Forces of the Democratic Republic of the Congo, marked World AIDS Day by launching an aggressive new education campaign to stop violence against women in the DRC and prevent the spread of HIV/AIDS in the military.
Drug combination delivered by nanoparticles may keep melanoma from becoming resistant to treatment
The first of a new class of medication that delivers a combination of drugs by nanoparticle may keep melanoma from becoming resistant to treatment, according to Penn State College of Medicine researchers.
John Theurer Cancer Center plays major role in FDA's fast tracking of ipilimumab for metastatic melanoma
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 – the same day the agency accepted Bristol-Myers Squibb's application for the drug's approval and granted the application priority review status.
› Verified 4 days ago
Physical Therapists
Optometrists
Chiropractors
Occupational Therapists
Speech-Language Pathologists